• Ownership

Barbara Klencke - Insider Trading & Ownership

Entity
Individual
Location
C/O Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo, CA
Summary
The estimated net worth of Barbara Klencke is at least $1M dollars as of January 23, 2025. Barbara Klencke is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $644K. Barbara Klencke is the Director of ALX ONCOLOGY HOLDINGS INC and owns shares of ALX ONCOLOGY HOLDINGS INC (ALXO) stock worth about $216K. Barbara Klencke is the Director of Xencor Inc and owns shares of Xencor Inc (XNCR) stock worth about $141K.
All Insider Reports
All Insider Reports

Ownership of Barbara Klencke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TCRX TScan Therapeutics, Inc. Director $644K +$82.6K +14.7% Sep 23, 2024
ALXO ALX ONCOLOGY HOLDINGS INC Director $216K Jan 21, 2025
XNCR Xencor Inc Director $141K Jun 13, 2024
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 13, 2024
SRRA Sierra Oncology, Inc. Chief Medical Officer Jul 1, 2022

Insider Transactions Reported by Barbara Klencke:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.